Bryan Richard Sasmita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bryan Richard Sasmita has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Bi Huang
Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China
12 shared publications - Suxin Luo
Department of Cardiovascular Medicine, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, China
9 shared publications Suxin Luo
Department of Cardiology The First Affiliated Hospital of Chongqing Medical University Chongqing China
4 shared publicationsGang Liu
Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
2 shared publications- Siyuan Xie
Department of Laboratory Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
2 shared publications - Yi Jiang
Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China
2 shared publications
Latest Publications
- Open Access
- 15 August 2026
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 226
Differential myocardial responses to indobufen and aspirin across clinical and experimental models of myocardial infarction
- 15 August 2026
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 226
Open AccessDifferential myocardial responses to indobufen and aspirin across clinical and experimental models of myocardial infarction
- 1 January 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 447, 134142
Extracellular water to lean body mass ratio predicts mortality in patients with chronic heart failure: A prospective, observational study
- 1 January 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 447, 134142
Extracellular water to lean body mass ratio predicts mortality in patients with chronic heart failure: A prospective, observational study
- 25 June 2025
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 40 (15) , 3658-3667
Opioids in Critically Ill Acute Myocardial Infarction Patients: A Retrospective Analysis of the MIMIC-IV Database
Background Opioids are the most commonly prescribed analgesic for patients with critically ill acute myocardial infarction (AMI). Unfortunately, inconsistent findings and limited evidence leave healthcare providers uncertain about whether these drugs offer more benefit or harm. Hence, the present study aimed to evaluate the impact of opioid use in AMI patients admitted to the intensive care unit. Methods and Results A total of 5669 critically ill AMI patients’ data were extracted from the MIMIC-IV databases. Of which, 4044 patients received opioid analgesics, while 1625 did not. The primary outcome was an association between different types of opioids and all-cause mortality at 30, 90, and 365 days. During follow-up, patients who received opioids had significantly higher mortality rates compared to those who did not (30-day: 20.3% vs. 10.1%; 90-day: 28.0% vs. 15.8%; 365-day: 35.2% vs. 26.4%; all p < 0.001). After propensity score matching, multivariable Cox regression analysis identified morphine as the only opioid significantly associated with increased all-cause mortality at 30 days (HR 2.693 [95%CI 2.144–3.383], p < 0.001), 90 days (HR 2.151 [95%CI 1.757–2.632], p < 0.001), and 365 days (HR 1.709 [95%CI 1.435–2.036], p < 0.001). Furthermore, feature selection using the Boruta algorithm and SHAP summary plot highlighted opioid use, particularly morphine, as a key determinant of cumulative mortality. Conclusions Opioid use was a significant predictor of mortality in critically ill AMI patients. Notably, only morphine was independently associated with an increased risk of both short- and long-term mortality.
- 25 June 2025
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 40 (15) , 3658-3667
Opioids in Critically Ill Acute Myocardial Infarction Patients: A Retrospective Analysis of the MIMIC-IV Database
Background Opioids are the most commonly prescribed analgesic for patients with critically ill acute myocardial infarction (AMI). Unfortunately, inconsistent findings and limited evidence leave healthcare providers uncertain about whether these drugs offer more benefit or harm. Hence, the present study aimed to evaluate the impact of opioid use in AMI patients admitted to the intensive care unit. Methods and Results A total of 5669 critically ill AMI patients’ data were extracted from the MIMIC-IV databases. Of which, 4044 patients received opioid analgesics, while 1625 did not. The primary outcome was an association between different types of opioids and all-cause mortality at 30, 90, and 365 days. During follow-up, patients who received opioids had significantly higher mortality rates compared to those who did not (30-day: 20.3% vs. 10.1%; 90-day: 28.0% vs. 15.8%; 365-day: 35.2% vs. 26.4%; all p < 0.001). After propensity score matching, multivariable Cox regression analysis identified morphine as the only opioid significantly associated with increased all-cause mortality at 30 days (HR 2.693 [95%CI 2.144–3.383], p < 0.001), 90 days (HR 2.151 [95%CI 1.757–2.632], p < 0.001), and 365 days (HR 1.709 [95%CI 1.435–2.036], p < 0.001). Furthermore, feature selection using the Boruta algorithm and SHAP summary plot highlighted opioid use, particularly morphine, as a key determinant of cumulative mortality. Conclusions Opioid use was a significant predictor of mortality in critically ill AMI patients. Notably, only morphine was independently associated with an increased risk of both short- and long-term mortality.
- Open Access
- 16 April 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-11
Prognostic value of admission respiratory rate in patients with acute myocardial infarction
Respiratory rate (RR) is one important vital sign that is often neglected in patients with acute myocardial infarction (AMI). The present study aimed to evaluate the impact of admission RR on the prognosis in patients with AMI. This study included 5631 AMI patients from Medical Information Mart for Intensive Care IV (MIMIC-IV) and 1323 patients from The First Affiliated Hospital of Chongqing Medical University (validation cohort). The primary endpoint was 30-day all-cause mortality. Patients were divided into increased RR group (RR > 20 breaths/min) and normal RR group (RR ≤ 20 breaths/min) based on admission RR. In the MIMIC-IV cohort, the median age was 70 years and 3503 (62.2%) patients were male. Compared to patients with normal RR, patients with admission RR > 20 breaths/min had significantly increased risk of 30-day all-cause mortality (14.2% vs. 27.5%, p < 0.001). After multivariate adjustment, admission RR > 20 breaths/min was independently associated with increased risk of 30-day all-cause mortality (HR 1.715; 95%CI 1.507–1.952, p < 0.001). The findings from MIMIC-IV were validated in the data from The First Affiliated Hospital of Chongqing Medical University and the results were consistent. RR is not only a vital sign but also a simple and practical indicator for predicting the prognosis of patients with AMI. Increased RR upon admission independently predicted a higher risk of poor outcomes, making it a valuable tool for early risk stratification and guiding timely interventions.
- 16 April 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-11
Open AccessPrognostic value of admission respiratory rate in patients with acute myocardial infarction
Respiratory rate (RR) is one important vital sign that is often neglected in patients with acute myocardial infarction (AMI). The present study aimed to evaluate the impact of admission RR on the prognosis in patients with AMI. This study included 5631 AMI patients from Medical Information Mart for Intensive Care IV (MIMIC-IV) and 1323 patients from The First Affiliated Hospital of Chongqing Medical University (validation cohort). The primary endpoint was 30-day all-cause mortality. Patients were divided into increased RR group (RR > 20 breaths/min) and normal RR group (RR ≤ 20 breaths/min) based on admission RR. In the MIMIC-IV cohort, the median age was 70 years and 3503 (62.2%) patients were male. Compared to patients with normal RR, patients with admission RR > 20 breaths/min had significantly increased risk of 30-day all-cause mortality (14.2% vs. 27.5%, p < 0.001). After multivariate adjustment, admission RR > 20 breaths/min was independently associated with increased risk of 30-day all-cause mortality (HR 1.715; 95%CI 1.507–1.952, p < 0.001). The findings from MIMIC-IV were validated in the data from The First Affiliated Hospital of Chongqing Medical University and the results were consistent. RR is not only a vital sign but also a simple and practical indicator for predicting the prognosis of patients with AMI. Increased RR upon admission independently predicted a higher risk of poor outcomes, making it a valuable tool for early risk stratification and guiding timely interventions.
- Open Access
- 18 July 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (7) , 267
Prognostic Value of the Advanced Lung Cancer Inflammation Index Ratio in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Cohort Study
Background: Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) carries a high mortality risk. Inflammation and nutrition are involved in the pathogenesis and prognosis of both AMI and CS. The advanced lung cancer inflammation index ratio (ALI) combines the inflammatory and nutritional status. Our present study aimed to explore the prognostic value of ALI in patients with CS following AMI. Methods: In total, 217 consecutive patients with AMI complicated by CS were divided into two groups based on the ALI admissions cut-off: ≤12.69 and >12.69. The primary endpoint of this study was 30-day all-cause mortality. The secondary endpoints were gastrointestinal hemorrhage and major adverse cardiovascular events (MACEs), including 30-day all-cause mortality, atrioventricular block, ventricular tachycardia/ventricular fibrillation, and nonfatal stroke. The association of ALI with the study endpoints was analyzed by Cox regression analysis. Results: During the 30-day follow-up period after admission, 104 (47.9%) patients died and 150 (69.1%) suffered MACEs. The Kaplan–Meier analysis revealed significantly higher cumulative mortality and lower MACE rates in the low-ALI group compared to the high-ALI group (both log-rank p < 0.001). The 30-day mortality rate was significantly higher in patients with ALI ≤12.69 compared to ALI >12.69 (72.1% vs. 22.6%; p < 0.001). Furthermore, the incidence of MACEs was higher in patients with ALI ≤12.69 (85.6% vs. 51.9%; p < 0.001). The receiver operating curve showed that ALI had a modest predictive value (area under the curve [AUC]: 0.789, 95% confidence interval [CI]: 0.729, 0.850). After multivariable adjustment, ALI ≤12.69 was an independent predictor for both 30-day all-cause mortality (hazard ratio [HR]: 3.327; 95% CI: 2.053, 5.389; p < 0.001) and 30-day MACEs (HR: 2.250; 95% CI 1.553, 3.260; p < 0.001). Furthermore, the addition of ALI to a base model containing clinical and laboratory data statistically improved the predictive value. Conclusions: Assessing ALI levels upon admission can provide important information for the short-term prognostic assessment of patients with AMI complicated by CS. A lower ALI may serve as an independent predictor of increased 30-day all-cause mortality and MACEs.
- 18 July 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (7) , 267
Open AccessPrognostic Value of the Advanced Lung Cancer Inflammation Index Ratio in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Cohort Study
Background: Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) carries a high mortality risk. Inflammation and nutrition are involved in the pathogenesis and prognosis of both AMI and CS. The advanced lung cancer inflammation index ratio (ALI) combines the inflammatory and nutritional status. Our present study aimed to explore the prognostic value of ALI in patients with CS following AMI. Methods: In total, 217 consecutive patients with AMI complicated by CS were divided into two groups based on the ALI admissions cut-off: ≤12.69 and >12.69. The primary endpoint of this study was 30-day all-cause mortality. The secondary endpoints were gastrointestinal hemorrhage and major adverse cardiovascular events (MACEs), including 30-day all-cause mortality, atrioventricular block, ventricular tachycardia/ventricular fibrillation, and nonfatal stroke. The association of ALI with the study endpoints was analyzed by Cox regression analysis. Results: During the 30-day follow-up period after admission, 104 (47.9%) patients died and 150 (69.1%) suffered MACEs. The Kaplan–Meier analysis revealed significantly higher cumulative mortality and lower MACE rates in the low-ALI group compared to the high-ALI group (both log-rank p < 0.001). The 30-day mortality rate was significantly higher in patients with ALI ≤12.69 compared to ALI >12.69 (72.1% vs. 22.6%; p < 0.001). Furthermore, the incidence of MACEs was higher in patients with ALI ≤12.69 (85.6% vs. 51.9%; p < 0.001). The receiver operating curve showed that ALI had a modest predictive value (area under the curve [AUC]: 0.789, 95% confidence interval [CI]: 0.729, 0.850). After multivariable adjustment, ALI ≤12.69 was an independent predictor for both 30-day all-cause mortality (hazard ratio [HR]: 3.327; 95% CI: 2.053, 5.389; p < 0.001) and 30-day MACEs (HR: 2.250; 95% CI 1.553, 3.260; p < 0.001). Furthermore, the addition of ALI to a base model containing clinical and laboratory data statistically improved the predictive value. Conclusions: Assessing ALI levels upon admission can provide important information for the short-term prognostic assessment of patients with AMI complicated by CS. A lower ALI may serve as an independent predictor of increased 30-day all-cause mortality and MACEs.
- Open Access
- 22 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (12) , e37461
Prognostic value of red cell distribution width in non-ST elevation myocardial infarction: A cohort study
Non-ST elevation myocardial infarction (NSTEMI) has a higher risk of long-term mortality than ST-elevation myocardial infarction; thus, identifying such high-risk patients is essential. Red cell distribution width (RDW) recently emerged as a strong predictor of mortality in several cardiovascular diseases, however, it is scarcely known whether RDW has a prognostic value in NSTEMI patients, therefore, this study aims to elucidate this issue. 421 consecutive patients with NSTEMI between January 2020 and June 2022 were prospectively enrolled. Patients were divided into 2 groups by the optimal cutoff value of RDW using time-dependent receiver operating characteristic curves. The optimal cutoff value of RDW for predicting all-cause mortality was 13.4 and the study population was divided into low RDW (≤13.4) and high RDW (>13.4). The primary endpoint of this study was long-term all-cause mortality. The secondary endpoint was the association between RDW and long-term adverse events, including heart failure, gastrointestinal hemorrhage, stroke events, re-infarction rate, cardiovascular mortality, and major adverse cardiovascular events. The association of RDW with the outcome was analyzed by Cox regression analysis. Patients with high RDW tended to be older, had a higher history of previous MI, a higher history of percutaneous coronary intervention, a higher level of neutrophil, high-sensitivity C-reactive protein, a lower level of albumin, and a lower level of ejection fraction (all P < .05). During a median follow-up of 720 days (IQR, 534–913 days), the all-cause mortality was significantly higher in the high RDW group than in the low RDW group (24.8% vs 6.3%, P < .001). In the multivariate Cox proportional hazard analysis, RDW > 13.4 was an independent predictor for long-term all-cause mortality [hazard ratio 3.008; 95% confidence interval 1.005, 9.003, P = .049]. Admission RDW could be used as a new biomarker for predicting long-term mortality in patients with NSTEMI, and high RDW was associated with an increased risk of all-cause mortality.
- 22 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (12) , e37461
Open AccessPrognostic value of red cell distribution width in non-ST elevation myocardial infarction: A cohort study
Non-ST elevation myocardial infarction (NSTEMI) has a higher risk of long-term mortality than ST-elevation myocardial infarction; thus, identifying such high-risk patients is essential. Red cell distribution width (RDW) recently emerged as a strong predictor of mortality in several cardiovascular diseases, however, it is scarcely known whether RDW has a prognostic value in NSTEMI patients, therefore, this study aims to elucidate this issue. 421 consecutive patients with NSTEMI between January 2020 and June 2022 were prospectively enrolled. Patients were divided into 2 groups by the optimal cutoff value of RDW using time-dependent receiver operating characteristic curves. The optimal cutoff value of RDW for predicting all-cause mortality was 13.4 and the study population was divided into low RDW (≤13.4) and high RDW (>13.4). The primary endpoint of this study was long-term all-cause mortality. The secondary endpoint was the association between RDW and long-term adverse events, including heart failure, gastrointestinal hemorrhage, stroke events, re-infarction rate, cardiovascular mortality, and major adverse cardiovascular events. The association of RDW with the outcome was analyzed by Cox regression analysis. Patients with high RDW tended to be older, had a higher history of previous MI, a higher history of percutaneous coronary intervention, a higher level of neutrophil, high-sensitivity C-reactive protein, a lower level of albumin, and a lower level of ejection fraction (all P < .05). During a median follow-up of 720 days (IQR, 534–913 days), the all-cause mortality was significantly higher in the high RDW group than in the low RDW group (24.8% vs 6.3%, P < .001). In the multivariate Cox proportional hazard analysis, RDW > 13.4 was an independent predictor for long-term all-cause mortality [hazard ratio 3.008; 95% confidence interval 1.005, 9.003, P = .049]. Admission RDW could be used as a new biomarker for predicting long-term mortality in patients with NSTEMI, and high RDW was associated with an increased risk of all-cause mortality.
- Open Access
- 18 January 2024
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 19 (1) , 5
Edema Index Predicts Mortality in Patients with Chronic Heart Failure: A Prospective, Observational Study
Introduction: Chronic fluid accumulation or congestion is considered an important pathophysiologic mechanism in heart failure, leading to cardinal symptoms such as dyspnea, pulmonary congestion, and pitting edema. Edema index (EI) recently emerged as a surrogate for extracellular volume status and has been proven to be able to reflect one’s congestion status. In this study, we aimed to evaluate the prognostic value of EI in patients with chronic heart failure (CHF). Methods: A total of 401 consecutive patients with CHF between August 2019 and October 2021 were prospectively enrolled. EI was obtained by InBody S10. The primary endpoint was long-term all-cause and cardiovascular mortality. Results: Patients with high EI (>0.397) tended to be older, presented with atrial fibrillation, have higher N-terminal brain natriuretic peptide, and have higher creatinine (all p < 0.05). During a median follow-up of 1200 days, the all-cause and cardiovascular mortality rate was significantly higher in the high EI group compared to the low EI group (all-cause mortality rate 43.8% vs. 30.3%, p < 0.001, and cardiovascular mortality rate 17.5% vs. 13.0%, p < 0.001, respectively). In the multivariate Cox proportional hazard analysis, EI > 0.397 was an independent predictor for both all-cause mortality (HR 1.959; 95% CI 1.304, 2.944; p = 0.001) and cardiovascular mortality (HR 2.051; 95% CI 1.276, 3.296; p = 0.003). Conclusions: Admission EI could be used as a marker for predicting long-term mortality in patients with CHF, and higher EI was associated with an increased risk of all-cause and cardiovascular mortality. Furthermore, EI-guided management could be a promising therapy in patients with CHF.
- 18 January 2024
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 19 (1) , 5
Open AccessEdema Index Predicts Mortality in Patients with Chronic Heart Failure: A Prospective, Observational Study
Introduction: Chronic fluid accumulation or congestion is considered an important pathophysiologic mechanism in heart failure, leading to cardinal symptoms such as dyspnea, pulmonary congestion, and pitting edema. Edema index (EI) recently emerged as a surrogate for extracellular volume status and has been proven to be able to reflect one’s congestion status. In this study, we aimed to evaluate the prognostic value of EI in patients with chronic heart failure (CHF). Methods: A total of 401 consecutive patients with CHF between August 2019 and October 2021 were prospectively enrolled. EI was obtained by InBody S10. The primary endpoint was long-term all-cause and cardiovascular mortality. Results: Patients with high EI (>0.397) tended to be older, presented with atrial fibrillation, have higher N-terminal brain natriuretic peptide, and have higher creatinine (all p < 0.05). During a median follow-up of 1200 days, the all-cause and cardiovascular mortality rate was significantly higher in the high EI group compared to the low EI group (all-cause mortality rate 43.8% vs. 30.3%, p < 0.001, and cardiovascular mortality rate 17.5% vs. 13.0%, p < 0.001, respectively). In the multivariate Cox proportional hazard analysis, EI > 0.397 was an independent predictor for both all-cause mortality (HR 1.959; 95% CI 1.304, 2.944; p = 0.001) and cardiovascular mortality (HR 2.051; 95% CI 1.276, 3.296; p = 0.003). Conclusions: Admission EI could be used as a marker for predicting long-term mortality in patients with CHF, and higher EI was associated with an increased risk of all-cause and cardiovascular mortality. Furthermore, EI-guided management could be a promising therapy in patients with CHF.
- Open Access
- 27 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (43) , e35661
Electrocardiographic semi-spiked helmet sign in critically Ill patients: A case series
Rationale: ST-segment elevation on electrocardiogram (ECG) is an alarming sign. Although acute myocardial infarction (AMI) is the most common cause of ST-segment elevation, many non-ischemic conditions may produce pseudo-ST segment elevation. Spiked Helmet (SH) sign is one of the pseudo-ST segment elevations that is associated with critical illness and high risk of death. SH sign was characterized by an upward shift starting before the onset of the QRS complex; however, we found some patients presented with a peculiar characteristic on ECG with an upward convex ST-segment elevation after the QRS wave but without elevation before the QRS wave, therefore called Semi-SH sign. Also, this electrocardiographic feature exists in patients with critical disease and is related to poor prognosis. The purpose of this case series is to describe the electrocardiographic Semi-SH sign and enhance the awareness of such electrocardiographic manifestation for clinicians. Patients Concerns: This case series explores the possibility of severe infection induced electrocardiographic changes resembling spiked-helmet sign. Diagnoses: Sepsis-induced secondary myocardial injury or coronary vasospasm. Interventions: Gastric decompression, antibiotics, diuretics, advanced life support. Outcomes: The outcome of this case series is the association of the electrocardiographic Semi-SH sign with the prognosis. All 3 patients died several days post manifestation of electrocardiographic Semi-SH sign. Lesson: Like SH sign, electrocardiographic Semi-SH sign is a life-threatening or deadly ECG sign, and therefore early recognition and aggressive treatment are important.
- 27 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (43) , e35661
Open AccessElectrocardiographic semi-spiked helmet sign in critically Ill patients: A case series
Rationale: ST-segment elevation on electrocardiogram (ECG) is an alarming sign. Although acute myocardial infarction (AMI) is the most common cause of ST-segment elevation, many non-ischemic conditions may produce pseudo-ST segment elevation. Spiked Helmet (SH) sign is one of the pseudo-ST segment elevations that is associated with critical illness and high risk of death. SH sign was characterized by an upward shift starting before the onset of the QRS complex; however, we found some patients presented with a peculiar characteristic on ECG with an upward convex ST-segment elevation after the QRS wave but without elevation before the QRS wave, therefore called Semi-SH sign. Also, this electrocardiographic feature exists in patients with critical disease and is related to poor prognosis. The purpose of this case series is to describe the electrocardiographic Semi-SH sign and enhance the awareness of such electrocardiographic manifestation for clinicians. Patients Concerns: This case series explores the possibility of severe infection induced electrocardiographic changes resembling spiked-helmet sign. Diagnoses: Sepsis-induced secondary myocardial injury or coronary vasospasm. Interventions: Gastric decompression, antibiotics, diuretics, advanced life support. Outcomes: The outcome of this case series is the association of the electrocardiographic Semi-SH sign with the prognosis. All 3 patients died several days post manifestation of electrocardiographic Semi-SH sign. Lesson: Like SH sign, electrocardiographic Semi-SH sign is a life-threatening or deadly ECG sign, and therefore early recognition and aggressive treatment are important.
- Open Access
- 21 December 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (12)
Hyperkalemia mimicking de Winter T waves: A case report
“De Winter” electrocardiogram pattern is considered an equivalent risk to ST‐elevation myocardial infarction and usually indicates occlusion of the left anterior descending artery, which needs emergent revascularization treatment. However, some conditions can mimic “de Winter” electrocardiogram pattern and may cause misdiagnosis. Here, we reported a case of hyperkalemia presented with “de Winter‐like” electrocardiogram pattern. This study aimed to increase physicians' awareness about the impact of electrolyte disorder on electrocardiographic changes.
- 21 December 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (12)
Open AccessHyperkalemia mimicking de Winter T waves: A case report
“De Winter” electrocardiogram pattern is considered an equivalent risk to ST‐elevation myocardial infarction and usually indicates occlusion of the left anterior descending artery, which needs emergent revascularization treatment. However, some conditions can mimic “de Winter” electrocardiogram pattern and may cause misdiagnosis. Here, we reported a case of hyperkalemia presented with “de Winter‐like” electrocardiogram pattern. This study aimed to increase physicians' awareness about the impact of electrolyte disorder on electrocardiographic changes.
- Open Access
- 22 November 2022
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 49 (12) , 260
Association between Testosterone/Estradiol Ratio and Risk of Cardiometabolic Diseases in Women at Menopause Transition Age
Background: Imbalance of testosterone/estradiol ratio are frequently reported to be associated with the risk of cardiometabolic diseases; however, studies have yet to report the testosterone/estradiol ratio and its relationship to cardiometabolic diseases in women at menopause transition. This study aimed to explore the association between testosterone/estradiol ratio with cardiometabolic diseases in women during their menopausal transition age. Methods: 551 women aged from 45 to 55 years old were involved in this study. Their baseline information, disease comorbidity, blood biochemical tests, echocardiography and serum sex hormones were collected. Women were categorized by tertile distribution of testosterone/estradiol ratio. We used binary logistic regression model (for odds ratio) and poissoon loglinear model (for prevalence ratio) to evaluate the association between testosterone/estradiol ratio with cardiometabolic diseases. Results: The mean age of the study population was 48.6 ± 3.5 years old. Taking testosterone/estradiol ratio <3.9 as reference, the odds ratio with 95% confidence interval across the tertile groups for obesity were: 1.0 (reference), 2.32 (0.96–5.64), 4.70 (1.75–12.67) (p for trend = 0.002); for hypertension were: 1.0 (reference), 2.37 (1.45–3.86), 2.02 (1.12–3.62) (p for trend = 0.013); for cardiometabolic diseases were: 1.0 (reference), 2.29 (1.47–3.56), 2.34 (1.37–3.99) (p for trend = 0.013), compared with the prevalence ratio of 1.0 (reference), 1.64 (1.26–2.15), 1.65 (1.21–2.23) (p for trend = 0.001), respectively. Conclusions: Higher testosterone/estradiol ratio was associated with elevated prevalence of cardiometabolic diseases in women at menopause transition period.
- 22 November 2022
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 49 (12) , 260
Open AccessAssociation between Testosterone/Estradiol Ratio and Risk of Cardiometabolic Diseases in Women at Menopause Transition Age
Background: Imbalance of testosterone/estradiol ratio are frequently reported to be associated with the risk of cardiometabolic diseases; however, studies have yet to report the testosterone/estradiol ratio and its relationship to cardiometabolic diseases in women at menopause transition. This study aimed to explore the association between testosterone/estradiol ratio with cardiometabolic diseases in women during their menopausal transition age. Methods: 551 women aged from 45 to 55 years old were involved in this study. Their baseline information, disease comorbidity, blood biochemical tests, echocardiography and serum sex hormones were collected. Women were categorized by tertile distribution of testosterone/estradiol ratio. We used binary logistic regression model (for odds ratio) and poissoon loglinear model (for prevalence ratio) to evaluate the association between testosterone/estradiol ratio with cardiometabolic diseases. Results: The mean age of the study population was 48.6 ± 3.5 years old. Taking testosterone/estradiol ratio <3.9 as reference, the odds ratio with 95% confidence interval across the tertile groups for obesity were: 1.0 (reference), 2.32 (0.96–5.64), 4.70 (1.75–12.67) (p for trend = 0.002); for hypertension were: 1.0 (reference), 2.37 (1.45–3.86), 2.02 (1.12–3.62) (p for trend = 0.013); for cardiometabolic diseases were: 1.0 (reference), 2.29 (1.47–3.56), 2.34 (1.37–3.99) (p for trend = 0.013), compared with the prevalence ratio of 1.0 (reference), 1.64 (1.26–2.15), 1.65 (1.21–2.23) (p for trend = 0.001), respectively. Conclusions: Higher testosterone/estradiol ratio was associated with elevated prevalence of cardiometabolic diseases in women at menopause transition period.